Formac Pharmaceuticals Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
- Investors
-
5
Formac Pharmaceuticals General Information
Description
Developer of a drug delivery platform intended to offer pharmaceutical products focused on the formulation of poorly soluble active pharmaceutical ingredients. The company's platform offers drugs made using mesoporous silica materials that help in oral formulations of small organic drug compounds to enhance the oral bioavailability of poorly water-soluble active pharmaceutical ingredients, enabling physicians to overcome solubility-limited bioavailability.
Contact Information
Website
www.formacpharma.comCorporate Office
- Gaston Geenslaan 1
- Heverlee
- 3001 Leuven
- Belgium
Corporate Office
- Gaston Geenslaan 1
- Heverlee
- 3001 Leuven
- Belgium
Formac Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 31-Jan-2026 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jun-2016 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 08-Mar-2012 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 12-Aug-2010 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 07-Nov-2007 | $2.44M | $2.44M | Completed | Startup | |
| 1. University Spin-Out | 03-Oct-2007 | Completed | Startup |
Formac Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class G | ||||||||
| Class H | ||||||||
| Class F | ||||||||
| Class E | ||||||||
| Class D | ||||||||
| Class C | ||||||||
| Class B | ||||||||
| Class A1 | 15,500 | $1.33 | $1.33 | 1x | $1.33 | 0.12% | ||
| Ordinary | 555,201 | $1.33 | $1.33 | 1x | $1.33 | 4.48% |
Formac Pharmaceuticals Patents
Formac Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2015537029-A | Composition containing biologically active substance and irregular inorganic oxide | Pending | 14-Nov-2012 | ||
| JP-2022000430-A | Composition containing biologically active substance and irregular inorganic oxide | Pending | 14-Nov-2012 | ||
| EP-2919903-A1 | Compositions containing a biologically active material and a non-ordered inorganic oxide | Active | 14-Nov-2012 | ||
| EP-2919903-A4 | Compositions containing a biologically active material and a non-ordered inorganic oxide | Active | 14-Nov-2012 | ||
| EP-2919903-B1 | Compositions containing a biologically active material and a non-ordered inorganic oxide | Active | 14-Nov-2012 | A61K9/143 |
Formac Pharmaceuticals Signals
Formac Pharmaceuticals Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EASME - EU Executive Agency for SMEs | Corporation | |||
| Horizon 2020 | Government | |||
| Allegro Investment Fund | Venture Capital | Minority | ||
| PMV (Belgium) | Asset Manager | Minority | ||
| KU Leuven Research & Development | University | Minority |
Formac Pharmaceuticals FAQs
-
When was Formac Pharmaceuticals founded?
Formac Pharmaceuticals was founded in 2007.
-
Where is Formac Pharmaceuticals headquartered?
Formac Pharmaceuticals is headquartered in Leuven, Belgium.
-
What is the size of Formac Pharmaceuticals?
Formac Pharmaceuticals has 3 total employees.
-
What industry is Formac Pharmaceuticals in?
Formac Pharmaceuticals’s primary industry is Drug Delivery.
-
Is Formac Pharmaceuticals a private or public company?
Formac Pharmaceuticals is a Private company.
-
What is Formac Pharmaceuticals’s current revenue?
The current revenue for Formac Pharmaceuticals is .
-
How much funding has Formac Pharmaceuticals raised over time?
Formac Pharmaceuticals has raised $16M.
-
Who are Formac Pharmaceuticals’s investors?
EASME - EU Executive Agency for SMEs, Horizon 2020, Allegro Investment Fund, PMV (Belgium), and KU Leuven Research & Development have invested in Formac Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process